CS/SB 364 — Blood Establishments
by Health Regulation Committee and Senator Gaetz
This summary is provided for information only and does not represent the opinion of any Senator, Senate Officer, or Senate Office.
Prepared by: Health Regulation Committee (HR)
This bill creates a restricted prescription drug distributor permit under which a blood establishment may lawfully purchase, possess, and distribute certain prescription drugs to hospitals or other health care entities.
Local governments may not restrict the access to or use of public facilities or infrastructure for the collection of blood or blood components based on whether the blood establishment is operating as a for-profit or not-for-profit organization. Blood establishments may not base the service fee of blood or blood components provided to hospitals or other health care providers on whether the purchasing entity is a for-profit or not-for profit organization.
Blood establishments, with certain exceptions, that collect blood or blood components from volunteer donors in Florida must disclose information about the collection and distribution process; the volume of collections, purchases, and distributions; certain financial statements, and corporate ethical policies on the establishment’s Internet site. A blood establishment that fails to comply with these disclosures is subject to a civil penalty.
If approved by the Governor, these provisions take effect July 1, 2012.
Vote: Senate 40-0; House 116-1